Glucagon-like peptide-1 receptor agonists and muscle mass effects
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of obesity, demonstrating significant efficacy in inducing weight loss and improving metabolic parameters. However, emerging clinical and paraclinical evidence suggests that these agents may also contribute to an u...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-10-01
|
| Col·lecció: | Pharmacological Research |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1043661825003524 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
